跳至主要内容
临床试验/ACTRN12613000972729
ACTRN12613000972729尚未招募未知

Females aged between 16 and 25 years residing in Victoria, Australia, with 25 OHD levels between 25-74 nmol/L randomised to a behavioural intervention group (receiving the Safe-D m-Health mobile-based app), a pharmacological intervention (receiving Vitamin D3, 1000IU, daily by mouth) or a control group (general advice in the form of a pamphlet) for a period of 12 months, aiming to determine the effectiveness of the behavioural intervention to improve 25 OHD levels.

The University of Melbourne0 个研究点目标入组 234 人开始时间: 2013年9月2日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 25 Years(—)
性别
Female

入选标准

  • Residing in Victoria, Australia
  • Own and use a smartphone
  • 25 OHD levels between 25 and 75 nmol/

排除标准

  • Currently taking Vitamin D supplements over 800 IU daily
  • Unable to give informed consent
  • Currently pregnant, breastfeeding or planning to conceive during the study timeframes
  • Plan to move outside of Victoria during the study
  • Have ever had a melanoma or 1st degree relative diagnosed with melanoma
  • Health problems that may put participants at greater risk, or that may confound study results (sun sensitivity conditions, malabsorption conditions)

研究者

相似试验

Improving Vitamin D status and related health in... | 临床试验